Herd characteristics and cow-level factors associated with Prototheca mastitis
on dairy farms in Ontario, Canada by Pieper, L. et al.
5635
J. Dairy Sci.  95 :5635–5644
http://dx.doi.org/ 10.3168/jds.2011-5106 
© American Dairy Science Association®,  2012 .
 ABSTRACT 
Prototheca spp. are algae that cause incurable acute 
or chronic mastitis in dairy cows. The aim of this case-
control study was the identification of cow- and herd-
level risk factors for this unusual mastitis pathogen. 
Aseptically collected composite milk samples from 
2,428 milking cows in 23 case and 23 control herds were 
collected between January and May 2011. A question-
naire was administered to the producers, and cow-level 
production and demographic data were gathered. In 
58 of 64 isolates, Prototheca spp. and Prototheca zopfii
genotypes were differentiated using PCR and matrix-
assisted laser desorption/ionization time-of-flight mass 
spectrometry. All isolates were identified as Prototheca 
zopfii genotype 2. The mean within-herd prevalence 
for Prototheca spp. was 5.1% (range 0.0–12.5%). Case 
herds had a significantly lower herd-level prevalence of 
Staphylococcus aureus and a higher prevalence of yeasts 
than did control herds. The final logistic regression 
model for herd-level risk factors included use of intra-
mammary injections of a non-intramammary drug [odds 
ratio (OR) = 136.8], the number of different injectable 
antibiotic products being used (OR = 2.82), the use of 
any dry cow teat sealant (external OR = 80.0; internal 
OR = 34.2), and having treated 3 or more displaced 
abomasums in the last 12 mo OR = 44.7). The final 
logistic regression model for cow-level risk factors in-
cluded second or greater lactation (OR = 4.40) and the 
logarithm of the lactation-average somatic cell count 
(OR = 2.99). Unsanitary or repeated intramammary 
infusions, antibiotic treatment, and off-label use of in-
jectable drugs in the udder might promote Prototheca
udder infection. 
 Key words:   dairy cow ,  mastitis ,  Prototheca ,  case-
control study 
 INTRODUCTION 
Prototheca is a colorless, unicellular algae that can 
cause granulomatous mastitis in dairy cows. Prototheca 
spp. have been isolated from cases of clinical and sub-
clinical mastitis in several countries, including Canada 
(Dion, 1982), the United States (Pore et al., 1987; An-
derson and Walker, 1988; Jordan et al., 2003), Brazil 
(Costa et al., 1996; Corbellini et al., 2001; Bueno et 
al., 2006), Germany (Baumgärtner, 1997; Rösler and 
Hensel, 2003; Tenhagen et al., 2005; Möller et al., 2007), 
and Japan (Osumi et al., 2008). 
Prototheca spp. consists of Prototheca wickerhamii, 
Prototheca stagnora, Prototheca ulmea, Prototheca 
zopfii, Prototheca blaschkeae (Rösler et al., 2006), and
Prototheca cutis sp. nov. (Satoh et al., 2010). Prototheca 
zopfii genotype 2 (Möller et al., 2007; Aouay et al., 2008; 
Marques et al., 2008) and P. blaschkeae (Aouay et al., 
2008; Marques et al., 2008) have both been identified 
as causing clinical and subclinical mastitis. Prototheca 
zopfii genotype 1 has induced subclinical mastitis in 
challenge trials (Roth, 2009; Ito et al., 2011) but is gen-
erally not associated with naturally occurring mastitis. 
Of the rarely occurring cases of human protothecosis, a 
few have been associated with P. zopfii and P. blasch-
keae (Rösler et al., 2006; Lass-Flörl and Mayr, 2007; 
Zhang et al., 2010), suggesting a zoonotic potential of 
bovine disease due to those Prototheca species. 
 Different Prototheca species have been found in the 
dairy farm environment, usually in moist areas contain-
ing organic matter, such as mud (Anderson and Walk-
er, 1988), spoiled feed stored in silos (Baumgärtner, 
1997), leftover feed in mangers (Anderson and Walker, 
1988), and dirty water troughs (Anderson and Walker, 
1988; Costa et al., 1997). Additionally, they have been 
identified in feces of cows (Anderson and Walker, 1988; 
Enders and Weber, 1993; Costa et al., 1997), calves 
(Costa et al., 1997), sows (Pore and Shahan, 1988), 
sheep (Pore and Shahan, 1988), and rodents (Pore and 
Shahan, 1988). However, the isolation of Prototheca
from the dairy herd environment seems to be indepen-
dent from previous Prototheca isolation from mastitis 
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samples in the same herd (Blaschke-Hellmessen and 
Schuster, 1984; Anderson and Walker, 1988).
The prevalence of Prototheca spp. in routine milk 
samples is very low (0.1% of submitted samples) (Wil-
son et al., 1997). However, the prevalence of cows with 
Prototheca mastitis could reach more than 30% of the 
lactating herd during a Prototheca outbreak (Costa et 
al., 1997; Dubravka et al., 2006).
Because no treatment has yet been found to cure Pro-
totheca mastitis in vivo (Anderson and Walker, 1988; 
Lagneau, 1996; Jánosi et al., 2001), emphasis should 
be placed on identifying risk factors and implementing 
prevention strategies on affected dairy farms. The aim 
of this case-control study was to identify risk factors 




For this case-control study, 23 herds with repeated 
(2 or more) Prototheca-positive milk culture results 
from mastitis samples within the last 2 yr were selected 
by Ontario veterinarians. For selection of the control 
herds, the veterinarians named 4 suitable herds that 
could serve as controls. These farms needed to be 
similar to the respective case herds in the number of 
cows and stall type for milking cows, but with no his-
tory of Prototheca mastitis within the last 2 yr. Out 
of these 4 herds, the investigators randomly picked a 
control herd by drawing a herd name from a hat. The 
farms were included in the study if they were enrolled 
in milk recording through CanWest DHI (Guelph, ON, 
Canada). For 1 case-control pair, 2 additional control 
herds had to be sampled because the first and second 
herds originally enrolled as controls were found to have 
Prototheca-positive milk samples and a history of Pro-
totheca mastitis from more than 2 yr ago. All statistical 
analyses were performed without these 2 “false” control 
herds.
Between January 2011 and May 2011, the selected 
case and control herds were visited once during milk-
ing time by the researchers, the herd veterinarian, or a 
veterinary technician for aseptic collection of composite 
milk samples from each lactating cow. Dry cows were 
not sampled. Milk samples were taken after the usual 
premilking udder preparation by the farmer or milking 
staff, and before attachment of the milking unit. The 
teat ends were cleaned with an alcohol swab, the first 
few strips of milk were discarded, and a sample from 
all milking quarters was collected into one vial per cow. 
A clinical examination of the cows was not performed. 
Milk samples were submitted to the Animal Health 
Laboratory (University of Guelph, Ontario, Canada) 
for identification of Prototheca spp. and other mastitis 
pathogens. Ten microliters of each milk sample was 
plated on sheep blood agar plates (Oxoid Ltd., Bas-
ingstoke, UK) using a calibrated loop (Thermo Fisher 
Scientific Inc., Waltham, MA) and incubated at 35°C 
± 2°C for 48 h. Prototheca spp. were identified using 
colony morphology and Gram stain. Other mastitis 
pathogens were identified using colony morphology, 
Gram stain, and biochemical pattern according to Na-
tional Mastitis Council guidelines (Hogan et al., 1999). 
The laboratory personnel were blinded to case or con-
trol status of the sampled herds. A random subset of 
58 Prototheca isolates was shipped in slant agar tubes 
(Bio-Media Unlimited Ltd., Woodbridge, ON, Canada) 
to the Institute of Animal Hygiene and Environmental 
Health, Free University of Berlin (Berlin, Germany), 
for further species and genotype differentiation using 
PCR and matrix-assisted laser desorption/ionization 
time-of-flight mass spectrometry (MALDI-TOF MS; 
Bruker Daltonics, Bremen, Germany) with methods 
described previously (Rösler et al., 2006; von Bergen et 
al., 2009; Murugaiyan et al., 2012).
A questionnaire developed and pretested by the 
research team was administered via interview. The 
questionnaire contained 54 short questions about herd 
characteristics, management, and medication practices 
(Table 1). Further herd- and cow-level information was 
gathered using DHI records (Tables 1 and 2).
Statistical Analysis
Statistical analyses were conducted using the statisti-
cal software package STATA 10.1 (StataCorp, College 
Station, TX). For each herd and each mastitis patho-
gen, the within-herd prevalence was calculated by add-
ing up the number of isolates divided by the number of 
milk samples. The within-herd prevalence in case and 
control farms was compared using the Mann-Whitney 
U test. The following variables were created with in-
formation from the original questionnaire responses: 
changed dry cow treatment within the last 3 yr (yes/
no), number of different intramammary antibiotic 
mastitis treatment products (NrIntramam), number 
of different injectable antibiotic treatment products 
(NrInjectable; both continuous), and use of injectable 
sulfonamides (yes/no). The questionnaire data were 
screened for differences between case and control farms 
using descriptive statistics, univariable logistic regres-
sion for categorical variables, and the Mann-Whitney 
U test for continuous variables. Variables identified as 
risk factors (P < 0.1) were tested for collinearity using 
the Spearman rank correlation (ρ). High correlations 
(ρ > 0.6) were found between use of Spectramast LC 
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(Pfizer Animal Health, Pfizer Canada Inc., Kirkland, 
QC, Canada) as a lactating cow mastitis treatment 
and NrIntramam (ρ = 0.65) and between use of sulfon-
amides and NrInjectable (ρ = 0.61). The more general 
and biologically plausible variables NrIntramam and 
NrInjectable were tested first in the model.
Table 1. Descriptions and levels of risk factors for herd-level analyses (information gathered from questionnaire unless otherwise specified) 
Risk factor Description and levels
Herd size Count of milking and dry cows
Stall type For dry and milking cows separately: tiestall, freestall, bedded pack, other
Housing at calving Single cow in a tiestall, single cow in pen with pack, multiple 
cows in freestalls, multiple cows in a pen with pack, other
Bedding type1 For milking and dry cows separately: long straw, chopped straw, 
sawdust, sand, rubber mats, pasture mats, none, other
Source of drinking water for cows Dug well; drilled well; surface pond, stream, or river; municipal; other
Source of water for cleaning the milking equipment Dug well; drilled well; surface pond, stream, or river; municipal; other
Access to pond stream or river Any adult cow, at any time of the year: yes, no
Other animals on farm1 Dogs, cats, horses, pigs, sheep, goats, other, none
Frequency of cleaning feed bunk or manger For lactating and dry cows separately: more than once per day, once per 
day, every other day, once per week, less frequently than once per week
Access to pasture or yard At any time of the year, for pasture (>3 acres) and yard (≤3 acres) 
separately: dry cows, milking cows, dry and milking cows, none
Attended at shows or fairs During last 2 yr: yes, no
Purchased cattle1 Milking cows, heifers, calves (<6 mo), bulls
Flooring type For milking cows: slatted, solid, other
Type of milking system Pipeline, parlor, robotic
Automatic take-off Yes, no
Technical details of milking equipment Height of vacuum, pulsation rate, length of premilking 
stimulation time, yield at automatic take-off
Milking order None, independent from disease status; healthy cows before mastitis cows
Disinfection of milking unit between cows Yes, no
Premilking teat disinfection Premilking teat dip, wash with disinfectant only, 
wash with disinfectant and dry, none
Tool used to wipe teats before milking Reusable dry cloth towel, reusable damp cloth towel, single-use dry paper towel, 
single-use moist paper towel, single-use “baby wipe” type product, nothing, other
Postmilking teat dip Yes, no (if yes, application technique and product)
Wearing of milking gloves Farmer and milking staff: all do; no one does; some do, but not all
Disinfection of milking gloves or hands between cows Farmer and milking staff: all do; all do, at some 
cows; no one does; some do, but not all
Prestripping before milking unit attached On hand, shoe, or floor; on a strip cup or plate; not done
Antibiotic products for dry cow treatment Product name and duration of usage
Intramammary antibiotic mastitis treatment, injectable 
 mastitis treatment, teat channel dilators, udder creams 
 or balms
During the last year, names of products used
Teat sealant Internal, external, none (if used, product and duration of usage)
Teat surgeries During the last 2 yr: yes, no
Off-label drug use in the udder (ImINID) Yes, no (if yes, product name)
Number of cows with treatments During last year, for ketosis, displaced abomasum, mastitis, and lameness
Bacterial count,2 ×1,000 cfu/mL Over 12 mo, average monthly bulk tank bacterial count
Milk yield,3 kg Over 12 mo, average monthly milk yield per day and 305-d lactation
Milk components,3 kg Over 12 mo, average monthly milk fat and milk 
protein per day and 305-d lactation
SCC,2,3 ×1,000 cells/mL Over 12 mo, average monthly bulk tank SCC and weighted cow SCC
1Multiple answers possible.
2From Dairy Farmers of Ontario (DFO), Mississauga, ON, Canada
3From CanWest DHI (Guelph, ON, Canada) records.
Table 2. Description of risk factors for cow-level analyses from DHI records 
Risk factor Description
Lactation number Current lactation number
Milk yield, kg Milk production from last herd test-day and estimated over 305 d
Milk components, kg Milk fat and protein production from last herd test-day and estimated over 305 d
SCC, ×1,000 cells/mL SCC from last herd test-day and estimated over 305 d
Previous lactation number Lactation number in previous lactation
Previous lactation-average SCC, ×1,000 cells/mL SCC in previous lactation
Pedigree Cow’s dam and sire identification number
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Manual forward selection using a P-value of 0.05 
was chosen for logistic regression model building. Only 
biologically meaningful interactions were tested in the 
model. An interaction between NrInjectable and the 
intramammary injection of a non-intramammary drug 
(ImINID) was not significant (P = 0.64). Linearity 
was assessed for continuous variables and in the case 
of a nonlinear relationship between the predictor and 
outcome variable, the predictor variable was either 
transformed or categorized. The Hosmer-Lemeshow 
goodness-of-fit test was used to assess the model fit 
(5 groups, P = 0.36). By plotting raw residuals, stan-
dardized residuals, leverage, and delta-beta (influence 
of the specific covariate pattern on model)against the 
predicted outcome, covariate patterns that fit poorly in 
the model or that had a great influence on the model 
were visually identified. One covariate pattern was 
identified as very influential because of a high number 
of observations.
The model-building process described previously was 
repeated for the cow-level risk factors in case farms. 
Control farms were not included in these analyses, as 
the cows, by default, do not have a probability of hav-
ing a Prototheca-positive laboratory result. Logarithmic 
transformation was performed on all SCC variables 
before the analyses. Risk factors were compared among 
cows with Prototheca-positive, culture-negative, and 
other mastitis pathogen-positive laboratory results 
using the Kruskal-Wallis rank sum test, and for post 
hoc comparisons, the Mann-Whitney U test. High cor-
relations were found between lactation number and 
cow age in days (ρ = 0.93), and test-day SCC and 
lactation-average SCC (ρ = 0.80). Lactation number 
and lactation average SCC were, as the more informa-
tive variables, tested in the model. Cows with mastitis 
pathogens other than Prototheca spp. were excluded 
from the final model for cow-level risk factors. An inter-
action term between age category and lactation-average 
SCC was not significant in the model (P = 0.71). The 
model fit was assessed using the Hosmer-Lemeshow 
goodness-of-fit test (5 groups, P = 0.21). Five covari-
ate patterns showed high Pearson residuals and high 
standardized residuals. Four were single observations 
of Prototheca-positive, first-lactation heifers with 
lactation-average SCC of 240,000 to 962,000 cells/mL. 
One covariate pattern consisted of 7 observations of 
first-lactation heifers with a lactation-average SCC of 
<50,000 cells/mL, whereas 1 of them had a Prototheca-
positive laboratory result. Only those 5 first-lactation 
heifers had Prototheca-positive laboratory results.
A random effects model accounting for clustering by 
herd was tested. It was not significantly different from 
the more parsimonious logistic regression model with-
out random effects (likelihood ratio test; P = 0.11). 
Therefore, the ordinary logistic regression model is 
shown in the results. A probability of P < 0.05 was 
considered significant in all analyses.
RESULTS
All cows in this study were Holstein-Friesian dairy 
cows. The mean number of cows in case and control 
herds was 66.9 (SD: 33.3) and 61.5 (SD: 20.3), respec-
tively. According to the CanWest DHI Progress Report 
for Ontario (CanWest, 2009), 82.3% of Ontario dairy 
herds keep from 1 to 99 cows. However, the mean 
number of cows in the study herds was lower than the 
average number of cows per herd based on that report. 
The 305-d milk production per cow in the study farms 
was lower than the average 305-d milk production of 
Holstein-Friesian cows in Ontario. Furthermore, the 
smaller size of the study herds was represented in the 
higher percentage of tiestalls compared with the aver-
age percentage of tiestalls in DHI dairy herds (Table 
3). Case and control herds did not differ significantly in 
305-d or test-day milk yield, fat yield, or protein yield 
per cow over the last 12 mo before sampling. Over the 
same period, case herds tended to have higher SCC (P 
= 0.06) and bacterial counts (P = 0.06) in the bulk 
tank milk compared with control herds. We found no 
difference in the number of times the producer exceeded 
the limits of 500,000 cells/mL (P = 0.23) or 50,000 cfu/
mL (P = 0.64) in bulk tank samples. The weighted 
average SCC over the last 12 mo before herd sampling 
were higher (P = 0.04) in case than in control herds.
Overall, 2,428 milk samples were cultured: 1,229 
from case farms and 1,199 from control farms. Culture-
negative results were obtained from 83.0% of all milk 
samples, and 0.62% of samples were contaminated. Sig-
nificant differences in within-herd prevalence between 
case and control herds were found for Prototheca spp., 
Staphylococcus aureus, and yeasts (Table 4). Prototheca 
spp. were isolated from 64 milk samples from 18 dif-
ferent herds. The within-herd prevalence of Prototheca 
spp. in case herds ranged from 0.0% to 12.5% of sam-
pled cows, with an average of 5.1%. In 5 case farms, no 
Prototheca spp. were isolated. The average within-herd 
prevalence for Staph. aureus in case herds was less than 
half that in control herds. Yeasts, Corynebacterium 
bovis, Enterobacter cloacae, Klebsiella spp., Escherichia 
coli, Proteus spp., and Enterococcus spp. were only 
isolated from case herd samples, whereas Streptococ-
cus agalactiae were only isolated from samples from 
1 control herd. Prototheca spp. were isolated together 
with Staph. aureus in 4 samples. Other combinations of 
pathogens were not observed. Using PCR and MALDI-
TOF MS, all analyzed isolates were identified as Pro-
totheca zopfii genotype 2. The isolates were similar to 
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the type and reference strains SAG 2021T, RZ II-2, and 
RZ II-3 (Culture Collection of the Institute of Animal 
Hygiene and Environmental Health, Free University of 
Berlin, Germany) that were previously isolated from 
clinical bovine mastitis in Germany.
Significant differences between case and control farms, 
based on univariable analysis of the questionnaire sec-
tions, are presented in Table 5. The use of an internal 
dry cow teat sealant was identified as a risk factor for 
being a case herd [odds ratio (OR) = 5.00, P = 0.033]. 
OrbeSeal (bismuth subnitrate, Pfizer Animal Health) 
was the only internal teat sealant used on the study 
farms. Most commonly, antibiotic dry cow treatment 
was administered to all cows at the end of lactation. On 
1 case and 1 control farm, only multiparous cows were 
treated, and on 4 control farms, cows only received 
dry treatment based on herd-specific conditions (e.g., 
high SCC). Interestingly, ImINID was identified as the 
strongest risk factor (OR = 9.6, P = 0.003). For this 
procedure, the producers most commonly used Predef 
2x (isuflupredone acetate, Pfizer Animal Health; 5 pro-
ducers), penicillin (Durvet Inc., Blue Springs, MO; 5 
producers), or Excenel RTU (ceftiofur hydrochloride, 
Pfizer Animal Health; 3 producers) as off-label intra-
mammary infusions.
Table 6 shows the mean number of different anti-
biotics used, as well as the mean frequency of disease 
treatments in case and control farms. Case farms used a 
significantly higher NrIntramam. Even though not sta-
tistically significant, the data suggest that case farms 
may also use a higher NrInjectable (P = 0.06). The 
frequencies of treatments were similar between case 
and control farms for the most common diseases, with 
exception of abomasal displacement. Case farms tended 
to have treated more abomasal displacements during 
the past 12-mo period (P = 0.051) than control farms.
We observed no differences in other analyzed risk fac-
tors between case and control farms. The final model for 
herd-level risk factors included ImINID (OR = 136.8), 
NrInjectable (OR = 2.82), the use of any dry cow teat 
sealant (external OR = 80.0; internal OR = 34.2), and 
having treated 3 or more displaced abomasums in the 
last 12 mo (≥3DA; OR = 44.7; Table 7).
For case farms, DHI data were available for 1,174 of 
1,229 sampled cows (95.5%). In case farms, cows with 
Prototheca-positive laboratory results were significantly 
Table 3. Demographic characteristics of case and control farms 
Parameter Case Control DHI1
Cows/herd, no. (SD) 66.9 (33.32) 61.5 (20.32) 75
305-d Milk production per cow, kg (SD) 9,304 (1,806.9) 9,271 (1,607.8) 9,650
Stall type for milking cows, no. (%)
 Tiestall 20 (87.0) 21 (91.2) 72.3
 Freestall 3 (13.0) 2 (8.7) 26.5
1CanWest DHI (2009).
Table 4. Mean, SD, minimum, and maximum within-herd prevalence (%) of isolated pathogens (number of isolates/number of cows sampled) 
in case and control herds 
Pathogen
Case (n = 23) Control (n = 23)
P-valueMean SD Minimum Maximum Mean SD Minimum Maximum
Prototheca spp. 5.14 3.97 0.00 12.50 0.00 0.00 0.00 0.00 <0.001
Staphylococcus aureus 5.59 4.95 0.00 14.29 12.12 10.14 0.00 34.00 0.03
CNS 1.70 2.56 0.00 8.70 2.59 3.43 0.00 12.07 0.31
Streptococcus dysgalactiae 0.16 0.74 0.00 3.57 0.24 0.83 0.00 3.57 0.57
Streptococcus agalactiae 0.00 0.00 0.00 0.00 0.45 2.14 0.00 10.26 0.32
Streptococcus uberis 0.31 0.76 0.00 2.78 0.53 1.78 0.00 7.14 0.48
Streptococcus spp. 0.17 0.82 0.00 3.92 0.21 0.70 0.00 2.50 0.59
Arcanobacterium pyogenes 0.56 1.25 0.00 4.55 0.97 1.56 0.00 5.00 0.30
Serratia mercescens 0.65 1.64 0.00 7.50 0.34 0.93 0.00 3.57 0.33
Pasteurella multocida 0.09 0.44 0.00 2.13 0.25 0.67 0.00 2.17 0.31
Yeasts 0.70 1.21 0.00 3.70 0.00 0.00 0.00 0.00 0.005
Corynebacterium bovis 0.25 1.03 0.00 4.88 0.00 0.00 0.00 0.00 0.15
Enterobacter cloacae 0.16 0.57 0.00 2.50 0.00 0.00 0.00 0.00 0.15
Klebsiella spp. 0.11 0.52 0.00 2.50 0.00 0.00 0.00 0.00 0.32
Escherichia coli 0.11 0.55 0.00 2.63 0.00 0.00 0.00 0.00 0.32
Proteus spp. 0.10 0.50 0.00 2.38 0.00 0.00 0.00 0.00 0.32
Enterococcus spp. 0.04 0.18 0.00 0.88 0.00 0.00 0.00 0.00 0.32
No bacterial pathogen 83.16 6.10 71.43 97.22 80.45 10.28 58.14 98.33 0.44
Overgrowth with contaminants 0.96 1.40 0.00 4.17 0.47 1.02 0.00 3.57 0.18
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Table 5. Univariable analysis of significant farm-level risk factors for being a case farm 
Parameter/question
Case (n = 23) Control (n = 23)
Odds  
ratio P-valueNo. % No. %
Access to pond, stream, or river at any time       
 Yes 0 0.0 4 17.4 0.0 0.036
Other animals on the farm1       
 Dogs 20 87.0 13 56.5 5.13 0.022
 Cats 21 91.3 21 91.3 1.00 1.000
 Horses 5 21.7 5 21.7 1.00 1.000
 Pigs 0 0.0 1 4.4 —  
 Goats 3 13.0 1 4.4 3.30 0.295
 Other 5 21.7 1 4.4 6.11 0.080
 None 0 0.0 1 4.4 —  
Wear milking gloves       
 All do 15 65.2 11 47.8 Referent  
 Some do, but not all 1 4.3 7 30.4 0.10 0.048
 No one does 7 30.4 5 21.7 1.02 0.970
Changed dry cow treatment within the last 3 yr       
 Yes 11 47.8 3 13.0 6.11 0.010
Teat sealant1       
 None 3 13.0 10 43.5 Referent  
 External 2 8.7 1 4.4 6.67 0.172
 Internal 18 78.3 12 52.2 5.0 0.033
Antibiotic intramammary mastitis treatment during lactation2,3     
 Special Formula 17900-Forte Suspension5 19 82.6 19 82.6 1.00 1.000
 Cefa-Lak6 12 52.2 10 43.5 1.42 0.555
 Pirsue Sterile Solution5 12 52.2 8 34.8 2.05 0.234
 Spectramast LC5 19 82.6 10 43.5 6.18 0.006
Sulfonamides (Borgal,7 Trivetrin,7 Trimidox8)3,4       
 Yes 21 91.3 15 65.2 5.60 0.032
Nonantibiotic mastitis treatment2,3       
 Banamine Sterile Solution Injectable7 9 39.1 5 21.7 2.31 0.200
 Anafen Injection 100 mg/mL9 11 47.8 7 30.4 2.10 0.227
 Aspirin10 11 47.8 5 21.7 3.30 0.063
 Predef 2x Sterile Aqueous Suspension5 9 39.1 3 13.0 4.29 0.044
 Oxitocin Injection11 5 21.7 5 21.7 1.0 1.000
 J-Vac9 1 4.4 1 4.4 1.0 1.000
 Other 7 30.4 4 17.4 2.08 0.300
Intramammary injection of a nonintramammary drug3       
 Yes 11 47.8 2 8.7 9.63 0.003
1Use of any teat sealant.
2Multiple answers possible.
3During the last 24 mo.
4Sulfonamides = use of any injectable sulfonamide.
5Pfizer Animal Health, Pfizer Canada Inc. (Kirkland, QC, Canada).
6Boehringer Ingelheim (Canada) Ltd. (Burlington, ON, Canada).
7Intervet/Schering-Plough Animal Health, Intervet Canada Corp. (Kirkland, QC, Canada).
8Vétoquinol Canada Inc. (Lavaltrie, QC, Canada).
9Merial Canada, Inc. (Baie d’Urfé, QC, Canada).
10Different manufacturers.
11Bimeda-MTC Animal Health Inc. (Lavaltrie, QC, Canada).
Table 6. Mean (SD) of number of different antibiotics used during the last 24 mo and of number of disease 
treatments in the last 12 mo in case and control farms 
Parameter Case (n = 23) Control (n = 23) P-value
Number of different intramammary antibiotics1 2.70 (0.93) 2.04 (0.88) 0.018
Number of different injectable antibiotics1 1.96 (1.19) 1.35 (1.07) 0.060
Ketosis2 9.00 (6.65) 8.04 (6.54) 0.565
Abomasal displacements2 4.17 (4.26) 2.96 (1.52) 0.051
Mastitis2 15.41 (14.92) 13.91 (16.38) 0.239
Lameness2 7.83 (9.17) 7.91 (6.84) 0.493
1During the last 24 mo.
2During the last 12 mo.
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older than cows with culture-negative results or cows 
with other mastitis pathogens (Table 8). Cows that 
tested positive or negative for Prototheca did not differ 
in stage of lactation or test-day milk, fat, or protein 
yields. Cows that were culture positive for Prototheca 
spp. or other mastitis pathogens had higher test-day 
SCC and lactation-average SCC than culture-negative 
cows. Four Prototheca-positive cows had test-day SCC 
<100,000 cells/mL, and 1 Prototheca-positive cow had 
a lactation-average SCC <100,000 cells/mL. Using the 
pedigree information from DHI, no mother-daughter 
pair could be detected among the Prototheca-positive 
cows in this study, and cows with Prototheca-positive 
laboratory results were offspring of many different 
sires. The final model for the cow-level risk factors 
(Table 9) indicates higher odds of having a laboratory 
result positive for Prototheca in multiparous cows and 
in those with high lactation-average SCC.
DISCUSSION
This case-control study was conducted to identify 
herd- and cow-level risk factors for Prototheca mastitis. 
Laboratory, production, and questionnaire data were 
compared for 23 case-control pairs of herds. Multivari-
able logistic regression models were utilized to predict 
the probability of being either a case farm or a Proto-
theca-positive cow in a case farm.
Case and control farms were similar to each other in 
basic demographic parameters. Furthermore, because 
82.3% of Ontario dairy farms have a herd size of <100 
cows, the studied farms can be considered representa-
tive of the majority of Ontario dairy farms in terms of 
herd size. Both case and control farms had a lower milk 
production per cow than average DHI farms, which 
might be associated with the smaller average herd size 
of the study farms.
A Prototheca spp. herd-level prevalence of 5.1% from 
our study is similar to that described in the literature for 
Table 7. Odds ratio (OR), 95% CI, and significance level of the final 
logistic regression model for herd-level risk factors for being a case 
herd 
Parameter1 OR 95% CI P-value
ImINID 136.8 5.40; 3,463.74 0.003
NrInjectable 2.82 1.043; 7.653 0.041
Teat sealant    
 None Referent — —
 External 80.0 1.11; 5,765.89 0.045
 Internal 34.2 2.22; 526.75 0.011
≥3 DA 41.1 2.69; 628.34 0.008
1ImINID = intramammary injection of a nonintramammary drug; 
NrInjectable = number of different injectable antibiotic products; Teat 
sealant = use of any teat sealant; ≥3 DA = having treated 3 or more 
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herds with endemic Prototheca mastitis (Baumgärtner, 
1997; Bueno et al., 2006). Among those isolates that 
were further investigated, only Prototheca zopfii geno-
type 2 was identified. This supports the predominant 
role of Prototheca zopfii genotype 2 in the pathogenesis 
of bovine mastitis caused by Prototheca spp. (Ahrholdt 
and Roesler, 2011).
Five case farms did not yield Prototheca-positive milk 
culture results. However, we decided to include those 
farms as cases because they met the predefined case 
definition, based on a history of repeated Prototheca 
spp. mastitis cases within the last 2 yr. In this study, 
where the herds were only cultured once using com-
posite milk samples, it is very likely to see one or more 
false-negative culture results based on the imperfect 
sensitivity of the test and the intermittent shedding 
of the organism. Furthermore, in small herds, such as 
those in Ontario, where very few cows are positive for 
Prototheca spp. at a given time, it is also likely that a 
Prototheca-infected cow had been culled for mastitis or 
other reasons in the period preceding the sampling day, 
and would therefore not appear in the culture results. 
Finally, because only lactating cows were sampled, 
Prototheca-positive cows that were dry at the time of 
the herd visit would not have been tested. In combina-
tion, all of these factors might have decreased the herd- 
and cow-level sensitivity of the culture results, and it 
is likely that the true prevalence of positive herds and 
cows was higher than detected in this study.
The mean within-herd prevalence of Staphylococcus 
aureus was considerably lower in case herds than in 
control herds. It might be that the veterinarians who 
selected the farms were biased in their choice and se-
lected controls with poor performance in terms of ud-
der health. This might have influenced the risk factor 
analyses and biased the estimates toward the null.
Several case reports about herds with outbreaks of 
Prototheca mastitis have described poor milking hy-
giene (lack of one or more of the following: prestrip-
ping, cleaning the udder prior to milking, disinfection 
of milking unit between cows, or postmilking teat dip) 
and wet, dirty, and muddy outdoor areas on those farms 
(Costa et al., 1996; Baumgärtner, 1997; Corbellini et 
al., 2001; Bueno et al., 2006). This case-control study 
is the first large-scale study that assessed farm-level 
risk factors objectively. Surprisingly, we did not find 
that specific farm characteristics, specific farm manage-
ment, or milking hygiene deficiencies were risk factors 
for Prototheca mastitis on the case farms.
Baumgärtner (1997) and Hodges et al. (1985) re-
ported problems with the milking equipment in farms 
where Prototheca outbreaks occurred. Most of the pro-
ducers in this study were unable to provide the precise 
technical data for milking equipment function on their 
farm. Therefore, an association between milking equip-
ment performance and Prototheca mastitis, if present, 
could not be detected in this study because of lack of 
appropriate data.
Other risk factors that have been mentioned in the 
literature were the extensive use of antibiotics, change 
of dry cow treatment, and unsanitary udder injections 
(Spalton, 1985; Corbellini et al., 2001; Jánosi et al., 
2001). In the current study, we found that variables 
associated with intramammary treatment (internal teat 
sealant, ImINID) and NrInjectable were farm-level risk 
factors for Prototheca mastitis. As in any case-control 
study, this association alone does not conclusively 
prove a cause-effect relationship. Producers might have 
implemented these practices in an effort to control 
Prototheca mastitis in their herds. It remains unclear 
whether Prototheca-positive cows were treated with 
these drugs, because treatment records for individual 
cows were not available. However, considering that 
yeasts were only found on case farms, this likely sug-
gests that Prototheca is, like yeast, an opportunistic 
pathogen. Furthermore, unsanitary udder injections 
might have introduced Prototheca spp. into the udder. 
Baumgärtner (1997) presumed that Prototheca infec-
tions are promoted by high infection pressure on af-
fected farms together with antibiotic treatments that 
inhibited the competitive natural udder flora.
The final logistic regression model for farm-level risk 
factors included the variable ≥3 DA. To our knowl-
edge, an association between displaced abomasum and 
mastitis caused by Prototheca has not been previously 
reported. A high number of displaced abomasums can 
be caused by factors such as poor ration formulation, 
poor feed hygiene and quality, or inadequate feed bunk 
management, all of which might be indicators of overall 
farm management and cleanliness.
Similar to the present study, Tenhagen et al. (1999) 
found that higher lactation number was a risk factor for 
Table 9. Odds ratio (OR), 95% CI, and significance level of the final logistic regression model for cow-level 
risk factors for Prototheca-positive laboratory results versus a culture-negative result (other mastitis pathogens 
excluded) in case farms 
Parameter OR 95% CI P-value
Second lactation or greater 4.40 1.697; 11.399 0.002
Log-transformed lactation-average SCC 2.99 2.295; 3.896 <0.001
Journal of Dairy Science Vol. 95 No. 10, 2012
RISK FACTORS FOR PROTOTHECA MASTITIS 5643
Prototheca mastitis. On the other hand, 25% of their 
Prototheca-positive cows were primiparous, whereas in 
our study, only 8.2% of affected cows were primiparous. 
The same study by Tenhagen et al. (1999) reported 
higher SCC during lactation in cows that were later af-
fected by Prototheca mastitis. Those authors suspected 
that the disrupted integrity of the udder tissue acted as 
a Prototheca mastitis-promoting factor.
The logistic regression model for cow-level risk factors 
suggested that culturing milk samples for Prototheca 
spp. from multiparous cows and those with high SCC 
might be an efficient way to screen for infected cows in 
farms where Prototheca spp. has been confirmed previ-
ously. Nevertheless, we found several culture-positive 
cows with test-day SCC <100,000 cells/mL and some 
primiparous cows with Prototheca-positive laboratory 
results. It might be that those cows with low SCC be-
came infected shortly after the DHI test day, or that 
a high SCC from the affected quarter was diluted in 
the composite DHI test sample due to agalactia caused 
by the Prototheca mastitis. On the other hand, SCC 
<100,000 cells/mL in cows with Prototheca zopfii infec-
tion have been reported in quarter and composite milk 
samples (Tenhagen et al., 2005; Bueno et al., 2006). As 
suggested (Rösler and Hensel, 2003; Bueno et al., 2006), 
eradication attempts should use repeated testing of the 
whole herd rather than testing only high-risk cows. 
Testing only the high-risk animals for Prototheca spp. 
might miss infected animals that could later perpetuate 
the infection in the herd. Furthermore, in the present 
study, composite milk samples, instead of quarter milk 
samples, were used for milk culture. This might have 
decreased the sensitivity of the laboratory culture re-
sults (Baumgärtner, 1997; Tenhagen et al., 2005) and 
biased the estimates of the cow-level parameters toward 
the null. It may be that Prototheca mastitis eradication 
attempts should use quarter milk samples.
The current work was a preliminary investigation. 
The sample size might have been too small and the data 
collection methods too general to detect differences in 
milking hygiene and farm management practices. The 
wide confidence intervals in the final herd-level model 
indicate uncertainty in the estimates because of the 
small sample size. Further research is needed to confirm 
the results, to investigate intramammary application 
hygiene, to objectively assess environmental hygiene, 
and to assess associations with milking equipment 
function. Moreover, in this study, prevalent instead of 
incident cases at the farm and cow levels were used. 
As such, a temporal pattern in support of a cause-
effect relationship could not be established. Last, the 
questionnaire administration was by interview, and the 
individual asking the questions was not blinded with 
respect to the status of the herd. This approach might 
have introduced bias and increased the magnitude of 
the observed associations. Special training for ques-
tionnaire administration was not provided. Neverthe-
less, mainly multiple-choice questions asking for farm 
practices during a specific time with discrete answer 
categories were used, leaving little room for misclas-
sification. Because the literature review that was used 
to develop the questionnaire revealed mainly anecdotal 
evidence of many different risk factors, the researchers 
did not know which of these risk factors would play a 
major role in the development of Prototheca mastitis 
on farm. Furthermore, a conscious effort was made to 
aim for neutral administration of questions during the 
interview.
CONCLUSIONS
Prototheca mastitis is an emerging disease that 
should be considered in the differential diagnosis of 
cases of mastitis that are nonresponsive to antibiotic 
treatment. Determination of mastitis-causing agents is 
necessary for effective therapy, timely culling decisions, 
and specific preventive interventions. A producer–vet-
erinarian relationship should be established and treat-
ment options discussed to avoid excessive, unsuccessful, 
and extra-label antibiotic use for mastitis. Prototheca 
spp. might act as an opportunistic pathogen and may 
be promoted by antibiotic-induced suppression of the 
natural udder flora.
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